COVID-19 vaccine makers fall as Biden says pandemic is over (update)

Sep. 19, 2022 3:00 PM ETModerna, Inc. (MRNA)JNJ, PFE, MRK, AZN, NVAX, VXRT, BNTX, CVAC, VAL, VALNBy: Dulan Lokuwithana, SA News Editor273 Comments

President Biden During Primetime Speech Outside Philadelphia"s Independence National Historical Park

Alex Wong/Getty Images News

Updated to add latest price moves.

Leading COVID-19 vaccine developers continued to decline towards Monday's close after President Joe Biden said that the pandemic is a thing of the past despite ongoing concerns related to the virus.

"The pandemic is over," he said Sunday during a 60 Minutes interview on the sidelines of the Detroit auto show, adding, "We still have a problem with COVID. We're still doing a lot of work on it. But the pandemic is over."

Shortly after 3:30PM EST, COVID-19 vaccine makers Moderna (NASDAQ:MRNA) and BioNTech (BNTX) were at $125.92 and$ 132.80 falling ~9% while Novavax (NVAX) and Vaxart (VXRT) were at $28.45 and $2.41 marking a ~7% decline, respectively.

European vaccine developers Valneva SE (VALN) and CureVac N.V. (CVAC) had also shed ~19% and ~5%, respectively.

Meanwhile, pharma giants with sizable COVID-19 franchises, Pfizer (PFE), Merck (MRK), Johnson & Johnson (JNJ), and AstraZeneca (AZN), are also in the red.

"If you notice, no one's wearing masks. Everybody seems to be in pretty good shape, and so I think it's changing, and I think [the Detroit auto show resuming after three years] is a perfect example of it," Biden noted during the CBS news interview.

The president's remarks suggest that COVID-19 Public Health Emergency (PHE) declaration is likely to end in January, leading to a potential end to extra federal Medicaid funding, Cowen analyst Rick Weissenstein wrote in a Monday note.

Read: Last week, the Director General of the World Health Organization (WHO), Tedros Adhanom Ghebreyesus, said that the world has never been in a better position to end the pandemic.

Recommended For You

Comments (273)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.